| Literature DB >> 12218602 |
Matthew M Heeney1, Kathleen Delgrosso, Robbi Robinson, Christine A Johnson, Charles W Daeschner, Thomas A Campbell, Saul Surrey, Russell E Ware.
Abstract
Newborn screening for hemoglobinopathies rarely produces a fetal hemoglobin only result; it is most consistent with beta-thalassemia major, although other diagnoses are possible. The authors describe two unrelated African-American babies born in North Carolina whose newborn screening revealed fetal hemoglobin only. Both had a relatively benign clinical and hematologic picture. Molecular analyses indicated that both children are compound heterozygotes for beta-thalassemia and pancellular (deletional) hereditary persistence of fetal hemoglobin, a rare and apparently benign condition. Accurate interpretation of the fetal hemoglobin only result on newborn screening requires thorough evaluation, including family studies and molecular analysis.Entities:
Mesh:
Substances:
Year: 2002 PMID: 12218602 DOI: 10.1097/00043426-200208000-00019
Source DB: PubMed Journal: J Pediatr Hematol Oncol ISSN: 1077-4114 Impact factor: 1.289